ID

15393

Descripción

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02150317

Link

https://clinicaltrials.gov/show/NCT02150317

Palabras clave

Versiones (1)
  1. 29/5/16 29/5/16 -
Subido en

29 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Advanced Hepatocellular Carcinoma NCT02150317

Inglés

Eligibility Advanced Hepatocellular Carcinoma NCT02150317

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female patients > 18 years and <=70 years of age.
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
at least 2 radiologic imaging showing characteristic features of hepatocellular carcinoma or cytologic/histologic evidence.
Descripción

hepatocellular carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2239176
tumor in liver and radiologically definable vascular invasion or extrahepatic metastasis.
Descripción

vascular invasion or extrahepatic metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0521157
UMLS CUI [2]
C0474915
criteria of liver function: child a-b level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
Descripción

child a-b level, serum bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4050412
UMLS CUI [2]
C0428441
no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal.
Descripción

major organs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026766
hb ≥90g/l,white blood cell count ≥3.000 cells/mm³,platelets ≥80.000 cells/mm³
Descripción

white blood cell count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023508
patients who can understand this trial and have signed informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of liver cancer.
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2]
C0009488
patients with a medical history of other malignant tumors
Descripción

Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
subjects participating in other clinical trials
Descripción

subjects participating in other clinical trials

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
liver function:child c
Descripción

Child-Pugh Class C

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3831115
no pathological evidence of hepatocellular carcinoma.
Descripción

no pathological evidence of hepatocellular carcinoma.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0205469
Volver a la parte superior de la página

Similar models

Eligibility Advanced Hepatocellular Carcinoma NCT02150317

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
male or female patients > 18 years and <=70 years of age.
boolean
C0001779 (UMLS CUI [1])
hepatocellular carcinoma
Item
at least 2 radiologic imaging showing characteristic features of hepatocellular carcinoma or cytologic/histologic evidence.
boolean
C2239176 (UMLS CUI [1])
vascular invasion or extrahepatic metastasis
Item
tumor in liver and radiologically definable vascular invasion or extrahepatic metastasis.
boolean
C0521157 (UMLS CUI [1])
C0474915 (UMLS CUI [2])
child a-b level, serum bilirubin
Item
criteria of liver function: child a-b level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
boolean
C4050412 (UMLS CUI [1])
C0428441 (UMLS CUI [2])
major organs
Item
no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal.
boolean
C0026766 (UMLS CUI [1])
white blood cell count
Item
hb ≥90g/l,white blood cell count ≥3.000 cells/mm³,platelets ≥80.000 cells/mm³
boolean
C0023508 (UMLS CUI [1])
informed consent
Item
patients who can understand this trial and have signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of liver cancer.
boolean
C0525058 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
Malignant Neoplasms
Item
patients with a medical history of other malignant tumors
boolean
C0006826 (UMLS CUI [1])
subjects participating in other clinical trials
Item
subjects participating in other clinical trials
boolean
C2348568 (UMLS CUI [1])
Child-Pugh Class C
Item
liver function:child c
boolean
C3831115 (UMLS CUI [1])
no pathological evidence of hepatocellular carcinoma.
Item
no pathological evidence of hepatocellular carcinoma.
boolean
C0205469 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial